NCT05927064View on ClinicalTrials.gov

Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients

CompletedOBSERVATIONAL

Enrollment

1,282

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2024

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis

Trial Locations (1)

54511

CHRU of Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER